Treatment of Hidradenitis Suppurativa Using Etanercept

Completed · Has a placebo group

Conditions studied: Hidradenitis Suppurativa

In brief

Therapy with etanercept, a TNF inhibitor will reverse the inflammation, symptoms and quality of life and allow healing of HS.

Key facts

Study ID
NCT00949546
Run by
Penn State University
People needed
20
Starts
2005-04-01
Expected to finish
2008-01-01
Last updated by the study team
2017-11-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.